General Information
- Drug Interactions (AIDS InfoNet) and Spanish version
- Drug Interactions (Project Inform) – fact sheet with links to sites that allow you to check medications for possible interactions
- Database of Antiretroviral Drug Interactions (HIV InSite)
- HIV Drug Interactions – web site with tools that allow you to check interactions between HIV drugs and other medications and street drugs
- Drug Interactions: A Comprehensive Listing of Potential Drug Interactions (Positively Aware)
- Be an Active Member of Your Health Care Team – U.S. Food and Drug Administration fact sheet that includes guidance on taking medications properly
Selected Recent Articles
- Epclusa demonstrates manageable drug interaction profile with commonly used ART. (September 2016, Healio)
- Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals (March 2016, AIDSmap); related coverage from Poz
- Taking Many Non-HIV Meds Is Linked to Shifts, Gaps in HIV Treatment. (February 2016, Poz)
- Hep C Drugs Pose Risk of Drug-Drug Interactions. (December 2015, Hepmag)
- Hepatitis C Treatment and Drug Interactions. (November 2015, Hepmag)
- HIV-treatment ‘booster drugs’ are most likely to have dangerous interactions with methamphetamine, mephedrone, MDMA and ketamine. (August 2015, AIDSmap)
- Harvoni and Sovaldi/Daclatasvir Safer to Mix With HIV Meds. (June 2015, Poz)
- HIV Is Linked to Getting a Buzz on Less Alcohol. (April 2015, Poz)
- Sovaldi or Harvoni and Heart Med Cordarone Can Be a Fatal Mix. (March 2015, Hepmag)
- Contraceptive implant levorongestrel may not be as effective when taking efavirenz (Sustiva) (March 2015, Project Inform)
- Coinfected People With Hep C May Have to Switch HIV Meds to Take Olysio. (March 2015, Poz)
- Patients with HIV/HCV may require ART switch to receive Olysio. (February 2015, Healio)
- Efavirenz decreases exposure to hormonal contraceptive implant. (November-December 2014, HIV Treatment Bulletin)
- Sovaldi-Ledipasvir Pill Safe With Major HIV Meds. (September 2014, Hepmag)
- AbbVie’s Hep C Regimen Is Safe with Opioid Replacement Therapy. (July 2014, Hepmag)
- Gilead’s Sovaldi-Ledipasvir Pill Safe With Major HIV Drugs. (May 2014, Poz)
- Ritonavir the cause of the interaction between telaprevir and ritonavir-boosted atazanavir. (November 2013, AIDSmap)
- Simultaneous HIV and tuberculosis therapy doesn’t cause problems with liver function. (October 2013, AIDSmap)
- New NNRTI MK-1439 interacts with ritonavir but not tenofovir. (September 2013, AIDSmap)
- Steroid Injections Mixed With PIs Threaten Cortisol Levels. (July 2013, Poz)
- Interaction between steroid injections and HIV protease inhibitors can disrupt cortisol levels. (June 2013, AIDSmap)
- Updated Opportunistic Infection Guidelines Add Info on IRIS, Hepatitis, Drug Interactions. (May 2013, HIVandhepatitis)
- Atripla Label Adds Interactions with Hepatitis C Drugs Boceprevir and Telaprevir. (April 2013, HIVandhepatitis)
- Concentrations of HIV protease inhibitors increase with age. (April 2013, AIDSmap)
- FDA Releases Updated Drug Interaction Information for Kaletra. (February 2013, Poz)
- Kaletra Label Updated to Add Drug Interactions, Including Boceprevir and Telaprevir. (January 2013, HIVandhepatitis)
- Combined oral contraception has less effect on nevirapine than efavirenz levels. (December 2012, AIDSmap)
- Certain Meds Mixed With Grapefruit Juice Can Be a Fatal Cocktail. (December 2012, Poz)
- Mixed Messages on Meds and Booze. (December 2012, Poz)
- High-Dose Vitamins Don’t Fight HIV and Can Raise Liver Levels. (November 2012, Poz)
- No Interactions Seen Between New TB Drug and Population HIV Meds. (August 2012, HIVandhepatitis)
- Co-administration of rifampicin and efavirenz does not reduce efavirenz concentrations or efficacy. (July 2012, AIDSmap)
- FDA to Docs: Best to Avoid Victrelis With Norvir-Boosted HIV Protease Inhibitors. (April 2012 by Poz)
- Studies look at interactions between new hepatitis C drugs and HIV antiretrovirals. (March 2012, AIDSmap)
- FDA updates guidance for use of HIV and hepatitis C protease inhibitors with statins. (March 2012, AIDSmap)
- Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors. (March 2012, Poz)
- Hep C, HIV Drug-Drug Interaction Studies Must Be a Priority, Activists Say. (February 2012, Poz)
- Merck Warns of Victrelis and HIV Protease Inhibitor Interactions. (February 2012, Poz)
- Guidelines published on management of interactions between anti-epileptic and anti-HIV drugs. (January 2012, AIDSmap)
- New Guidelines: Anti-Seizure Drug Selection for People Living With HIV. (January 2012, Poz)